List of Tables
Table 1. Global Non-Drug-Eluting Devices Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Non-Drug-Eluting Devices Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Non-Drug-Eluting Devices Market Competitive Situation by Manufacturers in 2025
Table 4. Global Non-Drug-Eluting Devices Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Non-Drug-Eluting Devices Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Non-Drug-Eluting Devices Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Non-Drug-Eluting Devices Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Non-Drug-Eluting Devices Average Price (K US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Non-Drug-Eluting Devices, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Non-Drug-Eluting Devices, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Non-Drug-Eluting Devices, Product Types and Applications
Table 12. Global Key Manufacturers of Non-Drug-Eluting Devices, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-Drug-Eluting Devices Companies by Tier (Tier 1, Tier 2, Tier 3), based on Non-Drug-Eluting Devices Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-Drug-Eluting Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Non-Drug-Eluting Devices Sales by Region (K Units), 2021–2026
Table 18. Global Non-Drug-Eluting Devices Sales Market Share by Region (2021–2026)
Table 19. Global Non-Drug-Eluting Devices Sales by Region (K Units), 2027–2032
Table 20. Global Non-Drug-Eluting Devices Sales Market Share by Region (2027–2032)
Table 21. Global Non-Drug-Eluting Devices Revenue by Region (US$ Million), 2021–2026
Table 22. Global Non-Drug-Eluting Devices Revenue Market Share by Region (2021–2026)
Table 23. Global Non-Drug-Eluting Devices Revenue by Region (US$ Million), 2027–2032
Table 24. Global Non-Drug-Eluting Devices Revenue Market Share by Region (2027–2032)
Table 25. North America Non-Drug-Eluting Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Non-Drug-Eluting Devices Sales by Country (K Units), 2021–2026
Table 27. North America Non-Drug-Eluting Devices Sales by Country (K Units), 2027–2032
Table 28. North America Non-Drug-Eluting Devices Revenue by Country (US$ Million), 2021–2026
Table 29. North America Non-Drug-Eluting Devices Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Non-Drug-Eluting Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Non-Drug-Eluting Devices Sales by Country (K Units), 2021–2026
Table 32. Europe Non-Drug-Eluting Devices Sales by Country (K Units), 2027–2032
Table 33. Europe Non-Drug-Eluting Devices Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Non-Drug-Eluting Devices Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Non-Drug-Eluting Devices Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Non-Drug-Eluting Devices Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Non-Drug-Eluting Devices Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Non-Drug-Eluting Devices Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Non-Drug-Eluting Devices Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Non-Drug-Eluting Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Non-Drug-Eluting Devices Sales by Country (K Units), 2021–2026
Table 42. Latin America Non-Drug-Eluting Devices Sales by Country (K Units), 2027–2032
Table 43. Latin America Non-Drug-Eluting Devices Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Non-Drug-Eluting Devices Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Non-Drug-Eluting Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Non-Drug-Eluting Devices Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Non-Drug-Eluting Devices Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Non-Drug-Eluting Devices Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Non-Drug-Eluting Devices Revenue by Country (US$ Million), 2027–2032
Table 50. Global Non-Drug-Eluting Devices Sales (K Units) by Type (2021–2026)
Table 51. Global Non-Drug-Eluting Devices Sales (K Units) by Type (2027–2032)
Table 52. Global Non-Drug-Eluting Devices Sales Market Share by Type (2021–2026)
Table 53. Global Non-Drug-Eluting Devices Sales Market Share by Type (2027–2032)
Table 54. Global Non-Drug-Eluting Devices Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Non-Drug-Eluting Devices Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Non-Drug-Eluting Devices Revenue Market Share by Type (2021–2026)
Table 57. Global Non-Drug-Eluting Devices Revenue Market Share by Type (2027–2032)
Table 58. Global Non-Drug-Eluting Devices Price (K US$/Unit) by Type (2021–2026)
Table 59. Global Non-Drug-Eluting Devices Price (K US$/Unit) by Type (2027–2032)
Table 60. Global Non-Drug-Eluting Devices Sales (K Units) by Application (2021–2026)
Table 61. Global Non-Drug-Eluting Devices Sales (K Units) by Application (2027–2032)
Table 62. Global Non-Drug-Eluting Devices Sales Market Share by Application (2021–2026)
Table 63. Global Non-Drug-Eluting Devices Sales Market Share by Application (2027–2032)
Table 64. Global Non-Drug-Eluting Devices Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Non-Drug-Eluting Devices Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Non-Drug-Eluting Devices Revenue Market Share by Application (2021–2026)
Table 67. Global Non-Drug-Eluting Devices Revenue Market Share by Application (2027–2032)
Table 68. Global Non-Drug-Eluting Devices Price (K US$/Unit) by Application (2021–2026)
Table 69. Global Non-Drug-Eluting Devices Price (K US$/Unit) by Application (2027–2032)
Table 70. Stryker Corporation Company Information
Table 71. Stryker Corporation Description and Business Overview
Table 72. Stryker Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 73. Stryker Corporation Non-Drug-Eluting Devices Product
Table 74. Stryker Corporation Recent Developments/Updates
Table 75. Medtronic Company Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 78. Medtronic Non-Drug-Eluting Devices Product
Table 79. Medtronic Recent Developments/Updates
Table 80. B. Braun Melsungen AG Company Information
Table 81. B. Braun Melsungen AG Description and Business Overview
Table 82. B. Braun Melsungen AG Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 83. B. Braun Melsungen AG Non-Drug-Eluting Devices Product
Table 84. B. Braun Melsungen AG Recent Developments/Updates
Table 85. Boston Scientific Corporation Company Information
Table 86. Boston Scientific Corporation Description and Business Overview
Table 87. Boston Scientific Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 88. Boston Scientific Corporation Non-Drug-Eluting Devices Product
Table 89. Boston Scientific Corporation Recent Developments/Updates
Table 90. ConMed Corporation Company Information
Table 91. ConMed Corporation Description and Business Overview
Table 92. ConMed Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 93. ConMed Corporation Non-Drug-Eluting Devices Product
Table 94. ConMed Corporation Recent Developments/Updates
Table 95. DemeTECH Corporation Company Information
Table 96. DemeTECH Corporation Description and Business Overview
Table 97. DemeTECH Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 98. DemeTECH Corporation Non-Drug-Eluting Devices Product
Table 99. DemeTECH Corporation Recent Developments/Updates
Table 100. Integra Lifesciences Company Information
Table 101. Integra Lifesciences Description and Business Overview
Table 102. Integra Lifesciences Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 103. Integra Lifesciences Non-Drug-Eluting Devices Product
Table 104. Integra Lifesciences Recent Developments/Updates
Table 105. Johnson & Johnson Company Information
Table 106. Johnson & Johnson Description and Business Overview
Table 107. Johnson & Johnson Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 108. Johnson & Johnson Non-Drug-Eluting Devices Product
Table 109. Johnson & Johnson Recent Developments/Updates
Table 110. Peter Surgical Company Information
Table 111. Peter Surgical Description and Business Overview
Table 112. Peter Surgical Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 113. Peter Surgical Non-Drug-Eluting Devices Product
Table 114. Peter Surgical Recent Developments/Updates
Table 115. Smith & Nephew plc. Company Information
Table 116. Smith & Nephew plc. Description and Business Overview
Table 117. Smith & Nephew plc. Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 118. Smith & Nephew plc. Non-Drug-Eluting Devices Product
Table 119. Smith & Nephew plc. Recent Developments/Updates
Table 120. Teleflex Incorporated Company Information
Table 121. Teleflex Incorporated Description and Business Overview
Table 122. Teleflex Incorporated Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 123. Teleflex Incorporated Non-Drug-Eluting Devices Product
Table 124. Teleflex Incorporated Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Non-Drug-Eluting Devices Distributors List
Table 128. Non-Drug-Eluting Devices Customers List
Table 129. Non-Drug-Eluting Devices Market Trends
Table 130. Non-Drug-Eluting Devices Market Drivers
Table 131. Non-Drug-Eluting Devices Market Challenges
Table 132. Non-Drug-Eluting Devices Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Non-Drug-Eluting Devices
Figure 2. Global Non-Drug-Eluting Devices Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Non-Drug-Eluting Devices Market Share by Type: 2025 & 2032
Figure 4. Implants Product Picture
Figure 5. Sutures Product Picture
Figure 6. Global Non-Drug-Eluting Devices Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Non-Drug-Eluting Devices Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Ambulatory Surgical Centers
Figure 10. Global Non-Drug-Eluting Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Non-Drug-Eluting Devices Market Size (US$ Million), 2021–2032
Figure 12. Global Non-Drug-Eluting Devices Sales (K Units), 2021–2032
Figure 13. Global Non-Drug-Eluting Devices Average Price (K US$/Unit), 2021–2032
Figure 14. Non-Drug-Eluting Devices Report Years Considered
Figure 15. Non-Drug-Eluting Devices Sales Share by Manufacturers in 2025
Figure 16. Global Non-Drug-Eluting Devices Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Non-Drug-Eluting Devices Players: Market Share by Revenue in Non-Drug-Eluting Devices in 2025
Figure 18. Non-Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Non-Drug-Eluting Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Non-Drug-Eluting Devices Sales Market Share by Country (2021–2032)
Figure 21. North America Non-Drug-Eluting Devices Revenue Market Share by Country (2021–2032)
Figure 22. United States Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Non-Drug-Eluting Devices Sales Market Share by Country (2021–2032)
Figure 25. Europe Non-Drug-Eluting Devices Revenue Market Share by Country (2021–2032)
Figure 26. Germany Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Non-Drug-Eluting Devices Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Non-Drug-Eluting Devices Revenue Market Share by Region (2021–2032)
Figure 33. China Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Non-Drug-Eluting Devices Sales Market Share by Country (2021–2032)
Figure 41. Latin America Non-Drug-Eluting Devices Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Non-Drug-Eluting Devices Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Non-Drug-Eluting Devices Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Non-Drug-Eluting Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Non-Drug-Eluting Devices by Type (2021–2032)
Figure 52. Global Revenue Market Share of Non-Drug-Eluting Devices by Type (2021–2032)
Figure 53. Global Non-Drug-Eluting Devices Price (K US$/Unit) by Type (2021–2032)
Figure 54. Global Sales Market Share of Non-Drug-Eluting Devices by Application (2021–2032)
Figure 55. Global Revenue Market Share of Non-Drug-Eluting Devices by Application (2021–2032)
Figure 56. Global Non-Drug-Eluting Devices Price (K US$/Unit) by Application (2021–2032)
Figure 57. Non-Drug-Eluting Devices Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
